General Considerations Chemicals
Hexafluorobenzene and decafluorobiphenyl were purchased from Oakwood Chemicals (West Columbia, SC). Decafluorobiphenyl sulfide was purchased from SynQuest Laboratories (Alachua, FL).
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP HCl) was purchased from Hampton Research (Aliso Viejo, CA). 2-(1H-Benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU), N,N-Dimethylformamide (DMF), dichloromethane (DCM), diethyl ether, HPLC-grade acetonitrile, and guanidine hydrochloride were obtained from VWR International (Philadelphia, PA). All other reagents were purchased from Sigma-Aldrich and used as received unless otherwise noted.
Glutathione S-transferase (GST)
GST from equine liver (Sigma-Aldrich catalog number: G6511) was received as lyophilized powder containing Tris and phosphate buffer salts, reduced glutathione, and EDTA. Water was added to dissolve the GST sample to a final concentration of 10 mg/mL followed by dialysis against 20 mM Tris, 150 mM NaCl, pH 7.5 buffer to remove reduced glutathione, and aliquots of GSTs were stored at -80 o C.
Human GST-M5 was cloned from pcDNA3-HA-GSTM5 (Addgene number: 11986) using Champion TM pET SUMO expression system (Life Technology) following manufacturer's recommended protocol. Aliquots of expressed GST-M5 were stored in 20 mM Tris, 150 mM NaCl, pH 7.5 buffer at 6 mg/mL concentration in -80 o C refrigerator.
Solid phase peptide synthesis
All peptides were synthesized on a 0.2 mmol scale using manual Fmoc-SPPS chemistry under flow [1] using 3 minutes cycle for each amino acid. Specifically, all reagents and solvents are delivered to a stainless steel reactor containing resins at a constant flow rate using HPLC pump; temperature of the reactor was maintained at 60 °C during the synthesis using water bath. Procedure for amino-acid residue coupling cycle contained 30 second coupling with 1 mmol Fmoc protected amino acids, 1.2 mmol HBTU, and 500 µL of diisopropyl ethyl amine (DIEA) in 2.5 mL of DMF, flow rate was 6 mL/min, note that for coupling of cysteine, 190 µL of DIEA was used to prevent racemization; 1 minute wash with DMF, flow rate was 20 mL/min; 20 seconds deprotection with 50% (v/v) piperidine in DMF, flow rate was 20 mL/min; and 1 minute wash with DMF, flow rate was 20 mL/min. The resin was washed thoroughly with DCM and air dried after completion of the stepwise SPPS. The peptide is then simultaneously cleaved from the resin and side-chain deprotected by treatment with 2.5% (v/v) water, 2.5% (v/v) 1,2-ethanedithiol (EDT), and 1% (v/v) triisoproprylsilane in neat trifluoroacetic acid (TFA) for 2 hours at room temperature. Resulting solution containing peptide was evaporated by blowing a stream of nitrogen gas over its surface for 15 minutes, then triturated and washed with cold diethyl ether three times. Obtained gummy-like solid was dissolved in 50% H 2 O: 50% acetonitrile containing 0.1% TFA and lyophilized. These same solvent compositions were used in most experiments and will be referred to as A: 0.1% TFA in H 2 O and B: 0.1% TFA in acetonitrile. All peptides were synthesized using MBHA resin, unless noted otherwise. Peptide 5 was synthesized using hydrazide resin [2] . All peptides containing glutathione tag at N-terminus were synthesized with Boc-α-Glu(OtBu)-OH as the last amino acid residue.
Peptide purification
The crude peptide was dissolved in 95% A: 5% B with 6 M guanidinium hydrochloride and purified by semi-preparative RP-HPLC (Agilent Zorbax SB C 18 column: 21.2 x 250 mm, 7 µm, linear gradient: 5-50% B over 90 min, flow rate: 5 mL/min). 1 µL of each HPLC fraction was mixed with 1 µL of alpha-cyano-4-hydroxycinnamic acid (CHCA) matrix in 75% A: 25% B, spotted with MALDI, and checked for fractions with desired molecular mass. The purity of fractions was confirmed by analytical RP-HPLC (Agilent Zorbax SB C 3 column: 2.1 x 150 mm, 5 µm, gradient: 0-2 minutes 5% B, 2-11 minutes 5-65% B, 11-12 minutes 65% B, flow rate: 0.8 mL/min). HPLC fractions containing only product material were confirmed by LC-MS analysis, combined, and then lyophilized. Peptides synthesized using fast flow-based SPPS and purified by RP-HPLC are listed in Table S1 .
LC-MS analysis
LC-MS chromatograms and associated mass spectra were acquired using Agilent 6520 ESI-Q-TOF mass spectrometer. Following LC methods were used:
Method A: Zorbax SB C 3 column: 2.1 x 150 mm, 5 µm, gradient: 0-2 minutes 5% B, 2-11 minutes 5-65% B, 11-12 minutes 65% B, flow rate: 0.8 mL/min.
Method B:
Zorbax SB C 18 column: 2.1 x 250 mm, 5 µm, gradient: 0-2 minutes 1% B, 2-15 minutes 1-70% B, 15-17 minutes 70% B, flow rate: 0.4 mL/min.
All samples were analyzed using Method A unless otherwise noted. Data was processed using Agilent Mass Hunter software package.
Y-axis in all chromatograms shown in supplementary figures represents total ion current
(TIC); mass spectrum insets correspond to the maxima point of the TIC peak.
Determination of reaction yields
All yields reported were determined by measuring total ion currents using LC-MS data. First, using Agilent Mass Hunter software package, the peak areas for all relevant peptidic species on the chromatogram were integrated. Then yield was calculated as following: %yield = S pro /S all where S pro is the peak area of the desired product and S all is the sum of all TIC peaks.
General Protocol for Preparation of S-Perfluoroarylated Peptides
Peptides 1a Peptides 2a−4a were prepared using the same protocol as 1a−1c by reacting peptide 2−4 with decafluorobiphenyl. Note that for preparation of peptides 3a and 4a, 20 mL of 90% A: 10% B was used as a quenching solution. Peptide 6a was prepared using the same protocol by reacting peptide 6 with decafluorobiphenyl.
LC-MS data for all reactions obtained in situ and RP-HPLC-purified products of peptides 1a to 1c and 2a−4a are summarized in Figure S1 and Figure S2 .
General Protocol for GST-catalyzed Peptide Macrocyclization
Macrocyclization reactions described in Figure 3 and Figure 4 were performed on a 100 µL scale. 10 µL of the peptide stock solution (1 mM in water), 2 µL of GST stock solution (10 mg/mL), 10 µL of 10X reaction buffer (1M phosphate, 200 mM TCEPHCl, pH 8.0), and 78 µL of water were combined in a vial (total volume of 100 µL). The reaction mixture was pipetted up and down for 20 times to ensure thorough mixing and left at room temperature (25 o C). 10 µL of the reaction mixture was quenched by addition of 100 µL of 50% A: 50% B, and subjected to LC-MS analysis.
Synthesis and Purification of Peptide 7
Peptide 7 was synthesized via hydrazide-based native chemical ligation protocol. by LC-MS analysis. After ligation for two hours, the product peptide 7 was purified by RP-HPLC ( Figure S15 ).
Expression and Purification of GST-M5
GST-M5 gene was amplified from pcDNA3-HA-GSTM5 (Addgene number: 11986) using primers: 5'-ATGCCCATGACTCTGGG and 5'-CTATTTGCTGTTCCATGTAGCTGAC, after gel purification, the gene was ligated into pET SUMO vector using protocol provided in Champion TM pET SUMO protein expression system manual. The N-terminal oligo-glycine sequence was introduced by site-directed mutagenesis using QuickChange Lightning Multi Site-Directed mutagenesis kit (Agilent) with primer: 5'-GGCTCACAGAGAACAGATTGGTGGTggtggtggtggcggcATGCCCATGACTCT-GGGG. The generated pET-SUMO-G5-GST-M5 construct encoded for the following protein sequence (G5-GST-M5 sequence is shown in bold):
E. coli BL21(DE3) cells transformed with pET-SUMO-G5-GST-M5 plasmid were grown in 1 L of LB medium containing kanamycin (30 µg/mL) at 37 ℃ until OD 600 = 0.6. Then, expression was induced by addition of 0.5 mM IPTG overnight at 30 ℃. After harvesting the cells by centrifugation (6,000 rpm, 10 min), the cell pellet was lysed by sonication in 25 mL of 50 mM Tris, 150 mM NaCl, pH 7.5 buffer containing 15 mg lysozyme (Calbiochem), 1 mg DNase I (Sigma-Aldrich), and 0.5 tablet of protease inhibitor cocktail (Roche Diagnostics, Germany). The suspension was centrifuged at 17,000 rpm for 30 min to remove cell debris. The supernatant was loaded onto a 5 mL HisTrap FF crude Ni-NTA column (GE Healthcare, UK), first washed with 40 mL of 20 mM Tris, 150 mM NaCl, pH 8.5, and then washed with 40 mL of 40 mM imidazole in 20 mM Tris, 150 mM NaCl, pH 8.5. The protein was eluted from the column with buffer containing 500 mM imidazole in 20 mM Tris, 150 mM NaCl, pH 8.5. Imidazole was removed from protein using HiPrep 26/10 Desalting column (GE Healthcare, UK), protein was eluted into 20 mM Tris, 150 mM NaCl, pH 7.5 buffer. Purified protein was analyzed using an Any kD Mini-PROTEAN TGX Precast Gel (Bio-Rad, CA). In addition, the protein was analyzed by LC-MS to confirm its purity and molecular weight.
SUMO group on SUMO-G5-GST-M5 was cleaved by incubating 1 µg of SUMO protease per mg protein at room temperature for 60 minutes. The crude reaction mixture was loaded onto a 5 mL HisTrap FF crude Ni-NTA column (GE Healthcare, UK) and the flow through containing G5-GST-M5 was collected. The protein was analyzed by LC-MS confirming sample purity and molecular weight (analyzed via high-resolution ESI-Q-TOF MS, observed mass: 25960.2, calculated mass: 25960.5). Figure S1 . Synthesis and purification of peptides 1a-c. Reaction conditions are described in the general protocol section. Chromatograms B, D, and F correspond to crude reactions used to prepare peptides 1a, 1b, and 1c, respectively; chromatograms C, E and G represent LC-MS analysis data for RP-HPLCpurified peptides 1a, 1b, and 1c, respectively. Chromatogram F was acquired using LC-MS method B. Figure S2 . Synthesis and purification of peptides 2a-4a. Shown are three series of chromatograms, each series consists of TIC chromatograms for LC-MS analysis of the pure substrate peptide, crude reaction mixture, and purified perfluoroaryl-linked peptide. A, B, and C are for peptide 2a; D, E, and F are for peptide 3a; G, H, and I are for peptide 4a. Peaks labeled with "*" denote side products with two peptides crosslinked by one decafluorobiphenyl molecule. 
2-4 2a-4a
n repeating peptide units Figure S3 . Macrocyclization of peptide 1a with and without GST analyzed by LC-MS at different time points. Reaction conditions are described in Figure 3 of the manuscript. Figure S4 . Macrocyclization of peptide 1b with and without GST analyzed by LC-MS at different time points. Reaction conditions are described in Figure 3 of the manuscript. Figure S5 . Macrocyclization of peptide 1c with and without GST analyzed by LC-MS at different time points. Reaction conditions are described in Figure 3 of the manuscript. [M+H] 1162.32 Figure S6 . Macrocyclization of peptide 2a with and without GST analyzed by LC-MS at different time points. Reaction conditions are described in Figure 4 of the manuscript. Figure S7 . Macrocyclization of peptide 3a with and without GST analyzed by LC-MS at different time points. Reaction conditions are described in Figure 4 of the manuscript. 
Reactions without enzyme
Figure S8. Macrocyclization of peptide 4a with and without GST analyzed by LC-MS at different time points. Reaction conditions are described in Figure 4 of the manuscript. 
Cyc-4a
Figure S9. Kinetic profiles for macrocyclization of peptides 1a-c. Yields were calculated from LC-MS analysis of the crude reaction mixture at different time points. All reactions with enzyme showed higher reaction rate than reactions without enzyme. Peptide 1a showed highest reaction rate under GST catalysis. Reaction conditions are same as those describe in Figure 3 of the manuscript. At each time point, 10 µL of the reaction mixture was quenched with 100 µL of 50% A: 50% B and was then subjected to LC-MS analysis. LC-MS chromatograms are summarized in Figure S3 -S5. Figure S10 . Kinetic profiles for macrocyclization of peptides 2a-4a. Yields are obtained from LC-MS analysis of the crude reaction mixture at different time points. Using Origin software, apparent rate constants of reactions are obtained by fitting the data with first-order kinetics using function: yield = 1−e -Kt where K is the apparent rate constant (min -1 ) and t is the time (min). Reaction conditions are same as those describe in Figure 4 of the manuscript. At each time point, 10 µL of the reaction mixture was quenched with 100 µL of 50% A: 50% B and was then subjected to LC-MS analysis. LC-MS chromatograms are summarized in Figure S6 -S8. Reactions without enzyme Tris base
Figure S14. Summary of macrocyclization yields of peptide 2a' to 4a' and peptide 2b to 4b in organic solvent.
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Figure S15. Synthesis and purification of peptide 7. TIC chromatograms for LC-MS analysis of crude peptide thioester 5a and RP-HPLC purified peptides 5, 6, 6a and 7. Peak labeled with "*" denotes thiolactone formed at the GSH cysteine from peptide 5a. Reaction conditions are described in section 4 of supporting information. Figure S17 . Cyclization of peptide 7 without GST catalyst. Reaction conditions: 0.1 mM peptide 7, 0.2 M phosphate, 20 mM TCEPHCl, pH 8.0, room temperature, 2 hours. The reaction lacks regioselectivity producing two isomers Cyc-7 and Cys-7' with arylation at both GSH cysteine and the NCL linkage cysteine, respectively. Peak corresponding to Cyc-7 was assigned based on retention time identity of the product obtained in the GST-catalyzed cyclization reaction shown in Figure 6 . Results show that GST regio-selectively catalyzed the cyclization at the GSH cysteine, and the central cysteine remained unmodified after GSTcatalyzed cyclization reaction. (A) LC-MS analysis of the crude GST-catalyzed ligation product before trypsin digestion (top chromatogram) and after trypsin digestion (bottom chromatogram). Reaction conditions for cyclization reaction were same as those described in Figure 5 . For trypsin digestion, 20 µL of the crude cyclization product was mixed with 20 µL of trypsin stock (100 µg/mL) and 1 µL of 1.5 M NH 4 HCO 3 . The mixture was incubated at 37 o C for 3 hours and was then subjected to LC-MS/MS analysis. The major product after trypsin digestion was identified as fragment (S14-K30), its mass spectrum is shown as the inset in bottom chromatogram. Cross-linked cysteines are labeled as C* and highlighted in red; arrows indicate the sites of trypsin digestion; sequence of the digested product fragment (S14-K30) is highlighted in blue. (B) MS/MS analysis of fragment (S14-K30), masses and sequences of identified ion species are listed in the 
